Quarterly Report III 20/21

September 2020 – May 2021, Diamyd Medical AB (publ), Fiscal year 2020/2021Developing precision medicine therapies for type 1 diabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B. Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2020 – May 31, 2021 · Net result: MSEK 87.3 (23.2), third quarter -32.7 (-7.2). The increase compared to previous year is a one-off effect of corresponding MSEK 144.4 due to profit from divestment